Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer
Authors:
- 1 December 2014
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (12) , 1598-1604
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancerAnnals of Oncology, 2013
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Vascular Smooth Muscle Cells Ablation with Endovascular Nonthermal Irreversible ElectroporationJournal of Vascular and Interventional Radiology, 2010
- Irreversible electroporation of the pancreas in swine: a pilot studyHPB, 2010
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus StatementAnnals of Surgical Oncology, 2009
- Tumor Ablation with Irreversible ElectroporationPLOS ONE, 2007
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary RegionAnnals of Surgery, 1999
- Pancreatic CarcinomaNew England Journal of Medicine, 1992